GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Core One Labs Inc (XCNQ:COOL) » Definitions » 3-Year EPS without NRI Growth Rate

Core One Labs (XCNQ:COOL) 3-Year EPS without NRI Growth Rate : 35.70% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Core One Labs 3-Year EPS without NRI Growth Rate?

Core One Labs's EPS without NRI for the three months ended in Dec. 2023 was C$-0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 35.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 30.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of Core One Labs was 59.10% per year. The lowest was -13.00% per year. And the median was 8.45% per year.


Competitive Comparison of Core One Labs's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Core One Labs's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core One Labs's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Core One Labs's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Core One Labs's 3-Year EPS without NRI Growth Rate falls into.



Core One Labs 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Core One Labs  (XCNQ:COOL) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Core One Labs 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Core One Labs's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Core One Labs (XCNQ:COOL) Business Description

Industry
Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5
Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.